Cite

HARVARD Citation

    Hoeper, M. et al. (2017). RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. European respiratory journal. 50 (3), p. . [Online]. 
  
Back to record